Aflac, a U.S. supplemental health insurance company, has given $100,000 to Children’s National Hospital in Washington, D.C., to support research…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted both orphan drug and rare pediatric disease designations to inclacumab and…
Hemex Health’s portable point-of-care device, Gazelle, is being enhanced to more precisely monitor fetal hemoglobin levels. According to…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Endari, an oral therapy approved to treat sickle cell disease (SCD) has been added to the Florida Medicaid…
Siklos (hydroxyurea) is now approved in the U.S. to reduce the frequency of painful crises and lower the need…
A lung ultrasound can aid in accurately diagnosing a serious respiratory complication called acute chest syndrome in children with…
Most children with sickle cell anemia (SCA), the most common and often the most severe form of sickle cell…
A new formulation of Oxbryta (voxelotor) that is suitable for treating children as young as 4 is now available…
Agios Pharmaceuticals has launched a Phase 2/3 trial called RISE UP to test its investigational therapy mitapivat (AG-348) in…